유바이오로직스: directors' dealings · South Korea · DART (FSS)

Explore the full insider trade history of 유바이오로직스, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 유바이오로직스 has published 15 public disclosures. Market capitalisation: €413.9bn. The latest transaction was reported on 3 April 2026 (Purchase). Among the most active insiders: 바이오노트. Every trade is free.